| |
| |
|
| Insider
Information: |
Alton Gregg H |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
61,846 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,756,942 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
61,846 |
|
|
| Total
Value |
$3,756,942 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
Chief Patient Officer |
2019-02-15 |
58,046 |
2018-02-20 |
0 |
Premium* |
|
|
Novavax Inc |
NVAX |
Director |
2023-06-10 |
3,800 |
2022-06-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
360 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 10 of 15
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2015-10-05 |
4 |
OE |
$24.30 |
$121,475 |
D/D |
5,000 |
138,422 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2015-10-05 |
4 |
AS |
$100.00 |
$500,000 |
D/D |
(5,000) |
133,422 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2015-10-26 |
4 |
OE |
$24.30 |
$121,475 |
D/D |
5,000 |
138,422 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2015-10-26 |
4 |
AS |
$110.00 |
$550,000 |
D/D |
(5,000) |
133,422 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2015-11-02 |
4 |
OE |
$24.30 |
$242,950 |
D/D |
10,000 |
143,422 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2015-11-02 |
4 |
AS |
$109.10 |
$1,312,507 |
D/D |
(12,000) |
131,422 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2015-12-01 |
4 |
AS |
$105.35 |
$1,272,159 |
D/D |
(12,000) |
129,422 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2015-12-01 |
4 |
OE |
$24.30 |
$242,950 |
D/D |
10,000 |
141,422 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• • – |
2016-02-15 |
4 |
A |
$76.02 |
$18,854 |
D/D |
248 |
129,670 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• • – |
2016-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
55,206 |
184,876 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• • – |
2016-02-16 |
4 |
D |
$91.15 |
$2,988,444 |
D/D |
(32,786) |
152,090 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• • – |
2016-03-14 |
4 |
AS |
$90.00 |
$450,000 |
D/D |
(5,000) |
147,090 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• • – |
2016-04-01 |
4 |
S |
$91.23 |
$456,158 |
D/D |
(5,000) |
142,090 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• • – |
2016-04-19 |
4 |
OE |
$26.99 |
$968,239 |
D/D |
35,874 |
177,964 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• • – |
2016-04-19 |
4 |
AS |
$100.00 |
$4,000,574 |
D/D |
(40,000) |
137,964 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2015-09-15 |
4 |
OE |
$24.30 |
$121,475 |
D/D |
5,000 |
140,422 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2015-09-15 |
4 |
AS |
$110.00 |
$550,000 |
D/D |
(5,000) |
135,422 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP,Corporate &Medical Affairs |
• • – |
2018-02-01 |
4 |
OE |
$40.56 |
$699,660 |
D/D |
17,250 |
62,738 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP,Corporate &Medical Affairs |
• • – |
2018-02-01 |
4 |
AS |
$83.29 |
$2,087,860 |
D/D |
(25,000) |
37,738 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP,Corporate &Medical Affairs |
• • – |
2018-02-15 |
4 |
A |
$62.35 |
$21,198 |
D/D |
340 |
38,078 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP,Corporate &Medical Affairs |
• • – |
2018-02-20 |
4 |
S |
$81.54 |
$1,176,992 |
I/I |
(14,435) |
0 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP,Corporate &Medical Affairs |
• • – |
2018-02-21 |
4 |
D |
$80.69 |
$475,587 |
D/D |
(5,894) |
52,176 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP,Corporate &Medical Affairs |
• • – |
2018-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
19,992 |
58,070 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP,Corporate &Medical Affairs |
• • – |
2018-03-01 |
4 |
OE |
$40.56 |
$699,660 |
D/D |
17,250 |
69,426 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP,Corporate &Medical Affairs |
• • – |
2018-03-01 |
4 |
AS |
$77.64 |
$1,967,315 |
D/D |
(25,000) |
44,426 |
0 |
- |
|
360 Records found
|
|
Page 10 of 15 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
